Ulocuplumab
- Product NameUlocuplumab
- CAS1375830-34-4
- CBNumberCB08080897
- MW0
- MOL FileMol file
- MSDS FileSDS
Chemical Properties
| form | Liquid |
| color | Colorless to light yellow |
| FDA UNII | 7KNP87L4X4 |
| NCI Drug Dictionary | ulocuplumab |
Ulocuplumab Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| ChemScene CS-0620946 | 1mg | $282 | Ulocuplumab 99.90% |
Buy |
| ChemScene CS-0620946 | 5mg | $845 | Ulocuplumab 99.90% |
Buy |
| ChemScene CS-0620946 | 10mg | $1354 | Ulocuplumab 99.90% |
Buy |
| ChemScene CS-0620946 | 25mg | $2437 | Ulocuplumab 99.90% |
Buy |
| ChemScene CS-0620946 | 50mg | $3900 | Ulocuplumab 99.90% |
Buy |
Ulocuplumab Chemical Properties,Usage,Production
Uses
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models[1][2].in vivo
Ulocuplumab (3-30 mg/kg; i.p.; every 3-4 days for 5 doses; 65 days in total) inhibits tumor growth of multiple myeloma xenograft models in mice, including Ramos B cells, HL-60 cells, MOLP-8 cells, Nomo-1 cells, and JJN-3R cells models[1].
| Animal Model: | Severe combined immunodeficient (SCID) mice of AML model (MOLP-8 cells)[1] |
| Dosage: | 3-30 mg/kg |
| Administration: | Intraperitoneal injection; every 3-4 days for 5 doses; last for 65 days |
| Result: | Significantly delayed mean tumor growth by 66% and 56% when compared with isotype control on day 25. |
IC 50
CXCR4References
[1] Kashyap MK, et al. Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. Oncotarget. 2016 Jan 19;7(3):2809-22. DOI:10.18632/oncotarget.6465[2] Kuhne MR, et al. BMS-936564/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies. Clin Cancer Res. 2013 Jan 15;19(2):357-66. DOI:10.1158/1078-0432.CCR-12-2333
Preparation Products And Raw materials
Ulocuplumab Suppliers
Global(26)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 18916372613 | yanzihan@shyuanye.com | China | 87240 | 60 | |
| 177-54423994 17754423994 |
2853530910@QQ.com | China | 8000 | 62 | |
| +1-781-999-5354; +1-00000000000 |
marketing@targetmol.com | United States | 32431 | 58 | |
| 15817493340 | 981810490@qq.com | China | 1577 | 58 | |
| 027-65317797 15926423062 |
422450190@qq.com | China | 10302 | 58 | |
| 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 | |
| 4008200310 15002144251 |
marketing@tsbiochem.com | China | 24951 | 58 | |
| 027-65279366 18108604356 |
products@biolabreagent.com | China | 9864 | 58 | |
| 13720134139 086-15871494362 13720134139 |
orders@jknbiochem.com | China | 7284 | 58 | |
| 021-65675885 18964387627 |
customer_service@efebio.com | China | 11963 | 58 |
View Latest Prices from Ulocuplumab manufacturers
1375830-34-4, UlocuplumabRelated Search
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine